⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine

h-index: 18
Total citations: 1,711
Total papers: 220

Homepage: http://www.duieih.kiev.ua/

Recent papers from L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of the National Academy of Medical Sciences of Ukraine

Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in 4 CountriesClinical Infectious Diseases · 2026
The Use of Unproven Drugs for COVID-19 Treatment in People Living with HIV in Central and Eastern EuropeGERMS · 2026
VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected UkraineAIDS · 2025
The status of hepatitis C microelimination among people living with HIV in Central and Eastern Europe in 2022 - data from Euroguidelines in Central and Eastern Europe Network Group.2025
Continuity of HIV and hepatitis C care in times of war – Five Times Ninety projectJournal of Infection and Public Health · 2025
Strategy of non-drug management of metabolic syndrome, which is accompanied by prediabetes and hypertensionINTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · 2025
Adding antibacterial/antiviral properties to medical purpose materials by modification with silver and copper nanoparticlesHimia Fizika ta Tehnologia Poverhni · 2025
Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16–24 weeksJournal of Virology · 2025
Prediction of Long-Term Treatment in Patients With Covid-19 Based on Analysis of Their Primary Examination DataEastern Ukrainian Medical Journal · 2025
High rates of deferring antiretroviral treatment for patients with HIV and substance use disorders: Results from a national sample of HIV physicians in UkrainePLoS ONE · 2024
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkersJournal of the International AIDS Society · 2024
Tuberculosis in combination with HIV infection and viral hepatitis: clinical caseInfusion & Chemotherapy · 2024
Etiology of Four Waves of the COVID-19 Pandemic in Ukraine according to the SARS-CoV-2 Virus Genome Sequencing Data: A Pilot StudyMicrobiology Research · 2024
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical TrialAdvances in respiratory medicine · 2024
Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks2024
Antiviral activity of Deschampsia antarctica plant extracts in vitroCzech Polar Reports · 2024
Активні компоненти флавоноїдного складу «Протефлазид» гальмують репродукцію вірусу грипу: можливі молекулярні мішені взаємодіїMikrobiolohichnyi Zhurnal · 2024
The Influence of Flavonoid Compositions on Nrf2 Transcription Factor Expression in Case of Infections Triggered by Influenza A Virus and Transmissible Gastroenteritis CoronavirusInnovative Biosystems and Bioengineering · 2023
HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern EuropeHIV Medicine · 2023
Population-level prevalence of detectable HIV viremia in people who inject drugs (PWID) in Ukraine: Implications for HIV treatment and case finding interventionsPLoS ONE · 2023